Lobbying client · LD-2 disclosures
Zynerba Pharmaceuticals, Inc.
Pennsylvania
41 filings from 2 registrants · 2015–2023 · latest filed Jan 8, 2024
Reported on its behalf
$530K
every LD-2 on file
Its own filed spend
$0
lobbying for itself
Fees to outside firms
$530K
across every firm on file
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who lobbies for them
Every outside firm that has filed on this client's behalf, by fees reported.
What they lobby on
Issue areas declared on the filings, ranked by how many filings name each one.
Pharmacy
PHA
26 filings
$525K on those filings
Government Issues
GOV
13 filings
$395K on those filings
Health Issues
HCR
Who did the lobbying
Every lobbyist named on this client's filings.
- Gregg L Harper Watkins & Eager PLLCCovered position: Former Member of U.S. House of Representatives14 filingsthrough 2023
- Edward John Allera Buchanan Ingersoll & Rooney PC14 filingsthrough 2020
- Michael P Strazzella Buchanan Ingersoll & Rooney PC14 filingsthrough 2020
- Elizabeth Westbrook Buchanan Ingersoll & Rooney PC12 filingsthrough 2020
Covered positions · 1 of 4 lobbyists named on these filings disclosed a prior government post. The text is reproduced exactly as filed.
The filings
The 20 most recent of 41 filings. Every figure above is built from these records.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: zynerba-pharmaceuticals-inc.